Next Article in Journal
Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor Antagonists
Next Article in Special Issue
How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva
Previous Article in Journal
Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine
Previous Article in Special Issue
Polypeptide Substrate Accessibility Hypothesis: Gain-of-Function R206H Mutation Allosterically Affects Activin Receptor-like Protein Kinase Activity
 
 
Article

Article Versions Notes

Biomolecules 2023, 13(9), 1364; https://doi.org/10.3390/biom13091364
Action Date Notes Link
article xml file uploaded 8 September 2023 06:25 CEST Original file -
article xml uploaded. 8 September 2023 06:25 CEST Update -
article pdf uploaded. 8 September 2023 06:25 CEST Version of Record https://www.mdpi.com/2218-273X/13/9/1364/pdf-vor
article supplementary file uploaded. 8 September 2023 06:25 CEST - https://www.mdpi.com/2218-273X/13/9/1364#supplementary
article html file updated 8 September 2023 06:27 CEST Original file -
article xml file uploaded 12 September 2023 03:37 CEST Update -
article xml uploaded. 12 September 2023 03:37 CEST Update -
article pdf uploaded. 12 September 2023 03:37 CEST Updated version of record https://www.mdpi.com/2218-273X/13/9/1364/pdf-vor
article html file updated 12 September 2023 03:39 CEST Update -
article xml file uploaded 12 September 2023 04:23 CEST Update -
article xml uploaded. 12 September 2023 04:23 CEST Update https://www.mdpi.com/2218-273X/13/9/1364/xml
article pdf uploaded. 12 September 2023 04:23 CEST Updated version of record https://www.mdpi.com/2218-273X/13/9/1364/pdf
article html file updated 12 September 2023 04:25 CEST Update -
article supplementary file uploaded. 12 September 2023 14:27 CEST - https://www.mdpi.com/2218-273X/13/9/1364#supplementary
article html file updated 12 September 2023 14:28 CEST Update https://www.mdpi.com/2218-273X/13/9/1364/html
Back to TopTop